These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11482734)

  • 1. Initial catabolic steps of isoleucine, the R-pathway and the origin of alloisoleucine.
    Mamer OA
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(1):49-55. PubMed ID: 11482734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 15N conservation in the metabolic conversion of isoleucine to alloisoleucine in the rat.
    Mamer OA; Lépine FL
    J Mass Spectrom; 1996 Dec; 31(12):1382-8. PubMed ID: 8990521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans.
    Mamer OA; Reimer ML
    J Biol Chem; 1992 Nov; 267(31):22141-7. PubMed ID: 1429566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloisoleucine formation in maple syrup urine disease: isotopic evidence for the mechanism.
    Matthews DE; Ben-Galim E; Haymond MW; Bier DM
    Pediatr Res; 1980 Jul; 14(7):854-7. PubMed ID: 7413299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transamination and oxidative decarboxylation of L-isoleucine, L-alloisoleucine and related 2-oxo acids in perfused rat hind limb muscle.
    Schadewaldt P; Radeck W; Hammen HW; Staib W
    Biochim Biophys Acta; 1989 Jul; 992(1):115-23. PubMed ID: 2568853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of L-alloisoleucine formation: studies on a healthy subject and in fibroblasts from normals and patients with maple syrup urine disease.
    Schadewaldt P; Hammen HW; Dalle-Feste C; Wendel U
    J Inherit Metab Dis; 1990; 13(2):137-50. PubMed ID: 2116545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenetic origin of the D-isoleucine and N-methyl-L-alloisoleucine residues in the actinomycins.
    Yajima T; Mason K; Katz E
    Antimicrob Agents Chemother; 1976 Feb; 9(2):224-32. PubMed ID: 57739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of L-alloisoleucine in vivo: an L-[13C]isoleucine study in man.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Pediatr Res; 2000 Feb; 47(2):271-7. PubMed ID: 10674358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective incorporation of isoleucine into Cypridina luciferin in Cypridina hilgendorfii (Vargula hilgendorfii).
    Kato S; Oba Y; Ojika M; Inouye S
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1528-32. PubMed ID: 16794342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease.
    Schadewaldt P; Bodner-Leidecker A; Hammen HW; Wendel U
    Clin Chem; 1999 Oct; 45(10):1734-40. PubMed ID: 10508118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of a new mammalian isoleucine catabolic pathway yielding an Rseries of metabolites.
    Mamer OA; Tjoa SS; Scriver CR; Klassen GA
    Biochem J; 1976 Dec; 160(3):417-26. PubMed ID: 1016232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An obstacle in preparing alloisoleucine.
    Laird WM; Matai S; Synge RL
    Biochem J; 1970 Mar; 116(5):911. PubMed ID: 5441379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racemization and amination of the keto-analog of isoleucine in the intact dog.
    Weinberg RB; Walser M
    Biochem Med; 1977 Apr; 17(2):164-72. PubMed ID: 856173
    [No Abstract]   [Full Text] [Related]  

  • 14. Racemization of amino acids in marine sediments.
    Wehmiller J; Hare PE
    Science; 1971 Sep; 173(4000):907-11. PubMed ID: 17751312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrogen sparing induced by a mixture of essential amino acids given chiefly as their keto-analogues during prolonged starvation in obese subjects.
    Sapir DG; Owen OE; Pozefsky T; Walser M
    J Clin Invest; 1974 Oct; 54(4):974-80. PubMed ID: 4430727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral L-alloisoleucine loading studies in healthy subjects and in patients with maple syrup urine disease.
    Schadewaldt P; Dalle-Feste C; Langenbeck U; Wendel U
    Pediatr Res; 1991 Nov; 30(5):430-4. PubMed ID: 1754297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.
    Bodner-Leidecker A; Wendel U; Saudubray JM; Schadewaldt P
    J Inherit Metab Dis; 2000 Dec; 23(8):805-18. PubMed ID: 11196106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of N-acetyl-DL-isoleucine, N-acetyl-DL-alloisoleucine and their ammonium salts; role of ammonium ions in crystal structure formation.
    Yajima T; Kimura M; Hori Y; Shiraiwa T
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Aug; 72(Pt 4):650-7. PubMed ID: 27484385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dietary substitution of racemic ketoanalogues for isoleucine in growing normal and uremic rats.
    Laouari D; Parvy PR; Burtin M; Kleinknecht C; Broyer M
    Am J Clin Nutr; 1990 Jun; 51(6):1046-53. PubMed ID: 2349918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of branched-chain alpha-keto acids on plasma amino acid concentrations in carbon tetrachloride-intoxicated rats.
    Okita M; Watanabe A; Takei N; Nagashima H; Ubuka T
    J Nutr; 1984 Jul; 114(7):1235-41. PubMed ID: 6737086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.